Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

LHRH antagonists disclosed by Takeda

June 21, 1996

Antitumor baccatin derivatives from Tanabe Seiyaku

June 21, 1996

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Cyclolignan derivatives disclosed

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

Further aldose reductase inhibitors from Sankyo

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...